Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

European CHMP issues opinion on Humira for severe axial spondyloarthritis

June 26, 2012

Ablynx reports on phase II extension study of ozoralizumab

June 26, 2012

Collaborating organizations design new GM-CSF-targeting products

June 22, 2012

NNC0109-0012 evaluated in phase I and II trials

June 22, 2012

Drug marketed for infertility shows promise to treat rheumatoid arthritis

June 22, 2012

Novel MMP inhibitors disclosed by Janssen Pharmaceutica

June 22, 2012

Janssen Pharmaceutica presents new matrix metalloproteinase inhibitors

June 21, 2012

Novel immunocytokine for rheumatoid arthritis shows promise in early-stage clinical trial

June 21, 2012

Innovimmune Biotherapeutics obtains NIH grant

June 15, 2012

Incyte synthesizes novel JAK-1 inhibitors

June 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...